Pregabalin-Mepha 20 mg/mL, Lösung zum Einnehmen

7680660000010 CH-66000 Lösung
Pregabalin-Mepha 20 mg/mL, Lösung zum Einnehmen
Pregabalin-Mepha 20 mg/mL, Lösung zum Einnehmen
Pregabalin-Mepha 20 mg/mL, Lösung zum Einnehmen
1 / 3
google

Article details

Package size
473
Selling units
473
Measure
ml
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/08/2025
Patient information leaflet
Français
19/08/2025
Patient information leaflet
Italien
19/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.755 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
0.16 MG Substance HBESI
(N/A)
1.3 MG Substance HBESI

Reimbursement information

Public price
CHF 69.45
Specialties list
Yes
Generic
Yes
SL addition date: 01/03/2016

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66000
Drug name
Pregabalin-Mepha, Lösung zum Einnehmen
Galenic form
LSOR
ATC Code
N02BF02
Authorization status
Z
Dispensing category
B
First authorization
30/12/2015
Authorization expiration date
31/12/9999
IT Number
01.07.1.
Domain
Human medicine
Field of application
Antiepilepticum, neuropathische Schmerzen, generalisierte Angststörungen

Package details

Description (FR)
PREGABALIN Mepha sol buvable 20 mg/ml 473 ml
Description (DE)
PREGABALIN Mepha Lös zum Einnehmen 20 mg/ml 473 ml
Market launch
30/12/2015
Narcotic (BTM)
No

Original drug

Lyrica, Hartkapseln
GTIN: 7680570570016
CHF 32.05
View original